• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Salvo Health Secures $10.5 Million in Seed Funding To Scale Virtual Health Clinic for Chronic Conditions

    8/9/22 9:00:00 AM ET
    $DOCS
    $RELY
    $LVGO
    EDP Services
    Technology
    Business Services
    Consumer Discretionary
    Get the next $DOCS alert in real time by email

    The virtual health clinic has launched to serve 60M+ Americans suffering from GI issues

    Salvo Health (https://www.salvohealth.com/), the virtual health clinic focusing on specialty care for chronic gut conditions, today announced the close of a $10.5 million seed funding investment led by Threshold Ventures along with Torch Capital and Felicis. These investors were early backers of healthcare innovators such as Livongo, Ro, and Brightline. Additional seed investors include founders from health transformers such as Ginger and Forward Health.

    Salvo Health is the first digital healthcare clinic delivering comprehensive and continuous gastro care. Members have unlimited messaging access to a care team, including a dedicated doctor, health coach, and care navigator, who offer care plans designed by leading experts in the GI field.

    Salvo Health is founded by veteran tech entrepreneurs who have helped digitize offline industries: Jeff Glueck, former CEO of Foursquare; Avi Dorfman, part of the founding team of Compass; and Jason Finger, co-founder of Seamless/Grubhub.

    "There is no quick-fix cure-all for chronic conditions like IBS or GERD, but with the right treatment approach from an expert team, and equipping our members with diverse strategies and tools, we can help people restore balance to their lives," said Jeff Glueck, Founder & CEO of Salvo Health. "The conventional medical system often underserves chronic GI conditions, so we assembled top minds to provide comprehensive and accessible care through an easy-to-use, app-based approach."

    Salvo Health's trademarked model of care, Whole Self Science, focuses on understanding how the entire body and lifestyle may impact overall gut health, allowing the care team to provide personalized and ongoing care to address root causes.

    For the first time, Salvo Health has brought together leaders from fields such as nutrition, psychology, gastroenterology, and microbiome science to guide a more comprehensive care model. Salvo Health's Clinical Advisory Board includes leading physicians from respected institutions such as the Cleveland Clinic's Center for Functional Medicine, Cedars-Sinai, and UCLA.

    The Clinical Advisory Board includes:

    • Dr. Mark Hyman, Senior Advisor of the Cleveland Clinic Center for Functional Medicine;
    • Dr. Mark Pimentel, Professor of Medicine at Cedars-Sinai and Executive Director of the MAST Program;
    • Dr. Emeran Mayer, founding Director of the UCLA Brain-Gut Microbiome Center;
    • Dr. Megan Oser, Clinical psychologist, expert in behavioral medicine and Director of Behavioral Medicine for Digestive Health at UCLA;
    • Dr. Frank Lipman, founder of the Eleven Eleven Wellness Center;
    • Chris Kresser M.S., L.Ac, founder of the Kresser Institute and a leading author and Functional Medicine clinician;
    • Dr. Laura Reigada, Ph.D., licensed clinical health psychologist on faculty at CUNY, and Co-Chair of the Rome Foundation's GastroPsych Membership Committee

    "There are only 15,400 board-certified gastroenterologists in the U.S. but over 60 million people live with chronic gut conditions. We need to forge new, affordable, and effective ways to provide ongoing care," said Emily Melton, Founder and Managing Partner at Threshold. "With Salvo Health, treatment is made accessible by bundling a program with specialist doctors, health coaches, programs from registered dieticians and psychologists into one monthly payment, a care plan that would typically cost hundreds to thousands of dollars a month out-of-pocket."

    "We love that Salvo Health's unique care model puts patients first, focusing on treating root causes rather than symptoms (which is how the existing healthcare system has historically treated gut issues),'' said Jonathan Keidan, Founder and Managing Partner of Torch Capital. "A platform like Salvo's is critical in changing health outcomes for these patients. Using their technology, they are able to drastically expand the population of patients who have access to this best-in-class care. We're thrilled to be investors as we know the huge impact they can have on the population who suffers these health conditions."

    Members can use their HSA/FSA funds to access a board-certified doctor, a board-certified health coach, and a custom treatment plan. Evidence-based care plans include brain-gut exercises designed by psychologists, gut-friendly nutrition recommendations from registered dieticians, microbiome health approaches, and sleep and stress practices. Doctors can help members access, as medically indicated, prescriptions and diagnostic testing as add-ons that generally are covered by health insurance. Support for members is available seven days a week.

    The company will use the seed funding to invest in its technology, expand to dozens more states, and build awareness via marketing. The virtual health clinic will also dedicate funding toward its research team studying user experiences and outcomes, which will contribute to medical studies on complex conditions and improvements to overall healthcare.

    Salvo Health is currently available in Calif., Fla., Ill., Mich., Ohio, N.J., N.Y., Pa., Texas, Tenn., Conn., Ky. and Va., with plans to expand to all 50 states. For more information and to sign up for a membership, please visit salvohealth.com.

    About Salvo Health

    Salvo Health is the virtual health clinic for chronic conditions. Salvo Health aims to radically increase access to the best of advanced specialty care, starting with the 60 million Americans impacted by chronic gut-related illnesses. Salvo Health uses a trademarked model of care called Whole Self Science, that considers overall health and contributing factors beyond the gut, to identify the root causes and provide personalized and continuous treatment plans. Members receive programs designed by world-renowned experts all through a mobile app. For more information please visit www.SalvoHealth.com.

    About Threshold Ventures

    Threshold Ventures is an early stage venture capital firm helping founders in healthcare and enterprise software bring their ideas to market. Our investments include BetterUp, Brightline, Doximity (NYSE:DOCS), LaunchDarkly, Livongo (NASDAQ:LVGO), Remitly (NASDAQ:RELY), Rippling, Talkdesk, and Viz.ai. Based on our work with these and dozens of other startups, we purpose-built Threshold so we can be the most effective partner for entrepreneurs at the early stages of building their companies. Learn more at www.threshold.vc.

    About Torch Capital

    Torch Capital is a New York-based, $200M early-stage venture capital firm that invests in the next generation of tech-enabled consumer brands and the infrastructure platforms that power them. Torch invests in customer-obsessed founders who use technology to make products and services more accessible, transparent, and affordable, whether the end-user is a person or business. Since launching in 2018, Torch has established itself as one of the top performing early-stage consumer technology funds in NYC. Torch Fund I investments include Ro, Acorns, Tia, Rho Banking, and Naadam, leaving the Fund's performance in the top decile of 2018 vintages. For more information visit: www.torchcapital.vc

    About Felicis

    Founded in 2006, Felicis is a venture capital firm investing in companies reinventing core markets, as well as those creating frontier technologies. Felicis focuses on early stage investments and currently manages over $2.1B in capital across 8 funds. The firm is an early backer of more than 45 companies valued at $1B+. More than 95 of its portfolio companies have been acquired or gone public, including Adyen (IPO), Credit Karma (acq by Intuit), Cruise (acq by General Motors), Fitbit (IPO), Guardant Health (IPO), Meraki (acq by Cisco), Ring (acq by Amazon), and Shopify (IPO). The firm is based in Menlo Park, CA. Learn more at www.felicis.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220809005457/en/

    Get the next $DOCS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DOCS
    $RELY
    $LVGO

    CompanyDatePrice TargetRatingAnalyst
    Doximity Inc.
    $DOCS
    7/9/2025$70.00In-line → Outperform
    Evercore ISI
    Doximity Inc.
    $DOCS
    6/2/2025$80.00Neutral → Buy
    BTIG Research
    Remitly Global Inc.
    $RELY
    5/8/2025$30.00 → $32.00Buy
    Monness Crespi & Hardt
    Doximity Inc.
    $DOCS
    2/7/2025$31.00 → $78.00Neutral → Overweight
    Piper Sandler
    Doximity Inc.
    $DOCS
    2/7/2025$60.00 → $90.00Market Perform → Outperform
    Leerink Partners
    Doximity Inc.
    $DOCS
    12/20/2024$55.00Equal-Weight
    Stephens
    Doximity Inc.
    $DOCS
    12/4/2024$55.00Neutral
    Mizuho
    Doximity Inc.
    $DOCS
    11/15/2024$58.00Neutral
    Goldman
    More analyst ratings

    $DOCS
    $RELY
    $LVGO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Remitly Announces Upcoming Webinar and Investor Conference Participation

    SEATTLE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly"), a trusted provider of digital financial services that transcend borders, today announced that its management team will present at the following webinar and investor conference: Post-Earnings Webinar with Goldman Sachs on Stablecoins and the Outlook for Cross-Border Date: Wednesday, August 13, 2025 Time: 1 p.m. Eastern Time / 10 a.m. Pacific Time Goldman Sachs Communacopia + Technology Conference 2025 Date: Wednesday, September 10, 2025 Time: 12:30 p.m. Eastern Time / 9:30 a.m. Pacific Time Please reach out to Will Nance, Goldman Sachs research analyst, at Will.Nance

    8/8/25 9:00:00 AM ET
    $RELY
    Business Services
    Consumer Discretionary

    Doximity Acquires Pathway, a Leader in AI Clinical Reference

    $63M acquisition brings physician AI team and datasets to Doximity's AI suite Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI and evidence-based clinical reference. Physicians make up half of Pathway's team. Over the past seven years, they've assembled one of the largest structured datasets in medicine—purpose-built for AI—spanning nearly every guideline, drug, and landmark trial across all major specialties. Pathway's model outperforms others in clinical accuracy, recently scoring a record 96% on the U.S. Medical Licensing Examination (

    8/7/25 4:02:00 PM ET
    $DOCS
    EDP Services
    Technology

    Doximity Announces Fiscal 2026 First Quarter Financial Results

    Total revenues of $145.9 million, up 15% year-over-year Operating cash flow of $62.1 million, up 51% year-over-year Free cash flow of $60.1 million, up 52% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 first quarter ended June 30, 2025. "We began our year with strong profit growth and record engagement across our newsfeed, workflow, and AI products," said Jeff Tangney, co-founder and CEO of Doximity. "Our AI suite once again grew the fastest, up 5x year-over-year, while more than 630,000 prescribers used our workflow tools to save time and better serve their patients." Doximity Acquire

    8/7/25 4:01:00 PM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    $RELY
    $LVGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Morris Nigel W bought $990,665 worth of shares (50,000 units at $19.81), increasing direct ownership by 3% to 1,800,213 units (SEC Form 4)

    4 - Remitly Global, Inc. (0001782170) (Issuer)

    11/7/23 8:06:47 AM ET
    $RELY
    Business Services
    Consumer Discretionary

    Morris Nigel W bought $4,818,509 worth of shares (250,000 units at $19.27), increasing direct ownership by 17% to 1,750,213 units (SEC Form 4)

    4 - Remitly Global, Inc. (0001782170) (Issuer)

    11/6/23 7:36:09 AM ET
    $RELY
    Business Services
    Consumer Discretionary

    $DOCS
    $RELY
    $LVGO
    Financials

    Live finance-specific insights

    View All

    Doximity Acquires Pathway, a Leader in AI Clinical Reference

    $63M acquisition brings physician AI team and datasets to Doximity's AI suite Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI and evidence-based clinical reference. Physicians make up half of Pathway's team. Over the past seven years, they've assembled one of the largest structured datasets in medicine—purpose-built for AI—spanning nearly every guideline, drug, and landmark trial across all major specialties. Pathway's model outperforms others in clinical accuracy, recently scoring a record 96% on the U.S. Medical Licensing Examination (

    8/7/25 4:02:00 PM ET
    $DOCS
    EDP Services
    Technology

    Doximity Announces Fiscal 2026 First Quarter Financial Results

    Total revenues of $145.9 million, up 15% year-over-year Operating cash flow of $62.1 million, up 51% year-over-year Free cash flow of $60.1 million, up 52% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 first quarter ended June 30, 2025. "We began our year with strong profit growth and record engagement across our newsfeed, workflow, and AI products," said Jeff Tangney, co-founder and CEO of Doximity. "Our AI suite once again grew the fastest, up 5x year-over-year, while more than 630,000 prescribers used our workflow tools to save time and better serve their patients." Doximity Acquire

    8/7/25 4:01:00 PM ET
    $DOCS
    EDP Services
    Technology

    Remitly to Report Second Quarter Financial Results on August 6, 2025

    SEATTLE, July 21, 2025 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly"), a trusted provider of digital financial services that transcend borders, today announced that it will report second quarter financial results after the market close on Wednesday, August 6, 2025. Management will host a conference call and live webcast to present the Company's financial results and answer questions from the financial analyst community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time that same evening. Conference call and webcast information can be found below. Remitly Second Quarter Financial Results Conference Call and Webcast Information:When: Wednesday, August 6th, 2025Time: 2:00

    7/21/25 4:05:00 PM ET
    $RELY
    Business Services
    Consumer Discretionary

    $DOCS
    $RELY
    $LVGO
    SEC Filings

    View All

    Doximity Inc. filed SEC Form 8-K: Leadership Update

    8-K - Doximity, Inc. (0001516513) (Filer)

    8/15/25 4:01:54 PM ET
    $DOCS
    EDP Services
    Technology

    SEC Form 144 filed by Remitly Global Inc.

    144 - Remitly Global, Inc. (0001782170) (Subject)

    8/14/25 4:24:07 PM ET
    $RELY
    Business Services
    Consumer Discretionary

    SEC Form 144 filed by Remitly Global Inc.

    144 - Remitly Global, Inc. (0001782170) (Subject)

    8/13/25 4:31:30 PM ET
    $RELY
    Business Services
    Consumer Discretionary

    $DOCS
    $RELY
    $LVGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Bryson Anna covered exercise/tax liability with 5,120 shares, decreasing direct ownership by 1% to 346,925 units (SEC Form 4)

    4 - Doximity, Inc. (0001516513) (Issuer)

    8/15/25 8:24:18 PM ET
    $DOCS
    EDP Services
    Technology

    Chief Executive Officer Tangney Jeffrey covered exercise/tax liability with 7,990 shares, decreasing direct ownership by 0.35% to 2,249,058 units (SEC Form 4)

    4 - Doximity, Inc. (0001516513) (Issuer)

    8/15/25 8:21:54 PM ET
    $DOCS
    EDP Services
    Technology

    Chief Business Officer Sharma Pankaj sold $178,550 worth of shares (9,000 units at $19.84), decreasing direct ownership by 5% to 182,926 units (SEC Form 4)

    4 - Remitly Global, Inc. (0001782170) (Issuer)

    8/14/25 7:37:37 PM ET
    $RELY
    Business Services
    Consumer Discretionary

    $DOCS
    $RELY
    $LVGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Doximity upgraded by Evercore ISI with a new price target

    Evercore ISI upgraded Doximity from In-line to Outperform and set a new price target of $70.00

    7/9/25 8:09:33 AM ET
    $DOCS
    EDP Services
    Technology

    Doximity upgraded by BTIG Research with a new price target

    BTIG Research upgraded Doximity from Neutral to Buy and set a new price target of $80.00

    6/2/25 8:38:31 AM ET
    $DOCS
    EDP Services
    Technology

    Monness Crespi & Hardt reiterated coverage on Remitly Global with a new price target

    Monness Crespi & Hardt reiterated coverage of Remitly Global with a rating of Buy and set a new price target of $32.00 from $30.00 previously

    5/8/25 7:31:41 AM ET
    $RELY
    Business Services
    Consumer Discretionary

    $DOCS
    $RELY
    $LVGO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Doximity Inc.

    SC 13G/A - Doximity, Inc. (0001516513) (Subject)

    11/14/24 5:22:01 PM ET
    $DOCS
    EDP Services
    Technology

    SEC Form SC 13G filed by Doximity Inc.

    SC 13G - Doximity, Inc. (0001516513) (Subject)

    11/14/24 11:42:53 AM ET
    $DOCS
    EDP Services
    Technology

    SEC Form SC 13G filed by Remitly Global Inc.

    SC 13G - Remitly Global, Inc. (0001782170) (Subject)

    11/13/24 7:32:47 PM ET
    $RELY
    Business Services
    Consumer Discretionary

    $DOCS
    $RELY
    $LVGO
    Leadership Updates

    Live Leadership Updates

    View All

    Parspec Raises $20 Million Series A to Modernize the Construction Supply Chain with AI

    SAN MATEO, Calif., July 8, 2025 /PRNewswire/ -- Parspec, an AI-native software platform that enables wholesale distributors and sales agents to efficiently bid and supply construction products, today announced it has raised $20 million in Series A funding. The round was led by Threshold Ventures (formerly DFJ), with participation from existing venture investors including Innovation Endeavors, Building Ventures, Heartland Ventures, and Hometeam Ventures. Parspec Raises $20 Million Series A to Modernize the Construction Supply Chain with AIThe global construction industry repres

    7/8/25 9:30:00 AM ET
    $BOX
    $DOCS
    $RELY
    Computer Software: Prepackaged Software
    Technology
    EDP Services
    Business Services

    Define Ventures Appoints Carolyn Magill as Venture Partner

    The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors SAN FRANCISCO, March 11, 2025 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Carolyn Magill, former CEO of Aetion, has joined the firm as venture partner. Magill, leveraging her 25 years of invaluable experience scaling companies and fostering innovation within payer, provider, and pharmaceutical organizations, will partner with Define founders to scale their companies and become category-defining companies.

    3/11/25 5:30:00 AM ET
    $EVH
    $HIMS
    $LVGO
    Other Consumer Services
    Consumer Discretionary
    Medical/Nursing Services
    Health Care

    Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

    With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera's efforts to scale robotics and AI across mainstream medical procedures. The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver high-quality care to pati

    9/26/24 6:05:00 AM ET
    $DOCS
    $RELY
    $LVGO
    EDP Services
    Technology
    Business Services
    Consumer Discretionary